Showing results (161-170 of 217) with videos related to

Sort By:
Pageof 22
Elife|November 29, 2017
The effect of perinatal brain injury on dopaminergic function and hippocampal volume in adult lifeSean Froudist-Walsh, Michael Ap Bloomfield, Mattia Veronese, et al.
Biological Psychiatry|June 25, 2025
Why Is Clozapine Uniquely Effective in Treatment-Resistant Schizophrenia? A Review and ProposalRobin M Murray, Alice Egerton, Yueming Gao, et al.
Schizophrenia Bulletin|December 14, 2011
Striatal dopamine transporter availability in drug-naive patients with schizophrenia: a case-control SPECT study with [(99m)Tc]-TRODAT-1 and a meta-analysisKao Chin Chen, Yen Kuang Yang, Oliver Howes, et al.
Translational Psychiatry|November 11, 2021
Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic functionPaul Allen, Emily J Hird, Natasza Orlov, et al.
The Australian and New Zealand Journal of Psychiatry|April 26, 2026
Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendationsNicola Warren, Cullen O'Gorman, Frances Dark, et al.
The International Journal of Neuropsychopharmacology|February 19, 2024
Histamine-3 Receptor Availability and Glutamate Levels in the Brain: A PET-1H-MRS Study of Patients With Schizophrenia and Healthy ControlsAtheeshaan Arumuham, Matthew M Nour, Mattia Veronese, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 19, 2016
Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET StudyEuitae Kim, Oliver D Howes, Mattia Veronese, et al.
The Lancet. Psychiatry|March 21, 2020
Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysisGuy Hindley, Katherine Beck, Faith Borgan, et al.
Human Brain Mapping|June 12, 2025
Single-Subject Network Analysis of FDOPA PET in Parkinson's Disease and Psychosis SpectrumMario Severino, Julia J Schubert, Giovanna Nordio, et al.
JAMA Psychiatry|July 4, 2019
In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode PsychosisFaith Borgan, Heikki Laurikainen, Mattia Veronese, et al.
Pageof 22